The substances treated during the Outpatient Rehab Program at Valley Spring Recovery Center include, but are not limited to alcohol, opioids, benzodiazepines, cocaine, methamphetamines, prescription medications, and hallucinogens. Many individuals in treatment also experience co-occurring mental health conditions such as anxiety, depression, and PTSD, which are addressed through therapy alongside substance use treatment.
The drugs that are treated during the Outpatient Rehab Program at Valley Spring Recovery Center in New Jersey include, but are not limited to:
Alcohol
A depressant that affects brain function and can lead to dependence. In 2022, there were 31,807 treatment admissions for alcohol use in New Jersey.
Opioids (e.g., heroin, morphine, oxycodone)
Prescription and illicit drugs that relieve pain but carry a high risk of addiction. In 2022, opioids were involved in a significant number of overdose deaths in New Jersey.
Benzodiazepines (e.g., Xanax, Valium)
Medications used for anxiety and sleep disorders that can cause physical dependence when misused. In 2022, there were 3,370 treatment admissions for benzodiazepine use in New Jersey.
Cocaine
A stimulant that increases energy and alertness but can lead to severe heart and mental health issues. In 2022, there were 5,005 treatment admissions for cocaine use in New Jersey.
Methamphetamines
A highly addictive stimulant that affects the nervous system and can cause long-term cognitive and psychological damage. In 2022, methamphetamine use contributed to a rising number of treatment admissions in New Jersey.
Prescription medications (e.g., Adderall, Ritalin)
Stimulants used to treat ADHD that, when misused, can lead to dependency and withdrawal symptoms.